Why the study?
Do serum hs-CRP and NT-proBNP predict myocardial infarction and death in patients with stable coronary artery disease?
Do serum hs-CRP and NT-proBNP predict myocardial infarction and death in patients with stable coronary artery disease?
In patients with stable CAD, NT-proBNP is a stronger predictor of MI and mortality than hs-CRP, and adding hs-CRP does not improve prognostic accuracy.
No takes yet. Share an insight, caveat, or question.
NT-proBNP may aid prognostication in stable CAD; observational data leaves integration into risk models open.
Harutyunyan et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: